Clinical Trial

Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH)

Name: Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) — clinical trial record (NCT07632898)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is a multicenter, open-label extension (OLE), single-arm study designed to assess the long-term safety and tolerability of oral IKT-001 administered once daily.

Trial Details

NCT Number	NCT07632898
Lead Sponsor	Inhibikase Therapeutics
Conditions	Pulmonary Arterial Hypertension (PAH)
Enrollment	484 participants
Start Date	2026-10-23
Primary Completion	2030-06-30 (estimated)
Study Completion	2030-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-08